跳至主要内容
临床试验/ACTRN12612000891820
ACTRN12612000891820进行中(未招募)4 期

Study of Neurocognitive Outcomes, Radiological and retinal effects of Aspirin in Sleep Apnoea to determine the effects of daily low-dose aspirin 100mg versus placebo on cognitive outcomes in the setting of sleep apnoea, in healthy older adults aged 70 and over.

Monash University0 个研究点目标入组 1,500 人开始时间: 2012年8月22日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
70 Years 至 o limit(—)
性别
All

入选标准

  • Enrolling into the parent ASPREE study.
  • Aged 70 and over
  • Able and willing to provide informed consent

排除标准

  • History of a diagnosed cardiovascular event, including AMI and stroke, atrial fibrillation, serious intercurrent illness likely to cause death within 5 years, cognitive impairment or dementia, disability, anaemia, a current or recurrent condition with a high risk of major bleeding, absolute contraindication or allergy to aspirin.
  • Also known history of sleep apnoea and/ or current use of continuous positive airways pressure (CPAP) at night

研究者

相似试验